|
1
|
Saslow D, Castle PE, Cox JT, Davey DD,
Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki
AB, et al: American cancer society guideline for human
papillomavirus (HPV) vaccine use to prevent cervical cancer and its
precursors. CA Cancer J Clin. 57:7–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steben M and Duarte-Franco E: Human
papillomavirus infection: Epidemiology and pathophysiology. Gynecol
Oncol. 107 2 Suppl 1:S2–S5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ginsburg O, Bray F, Coleman MP, Vanderpuye
V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, et
al: The global burden of women's cancers: A grand challenge in
global health. Lancet. 389:847–860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang A, Farmer E, Wu TC and Hung CF:
Perspectives for therapeutic HPV vaccine development. J Biomed Sci.
23:752016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll
P and Anastassiou D: A multi-cancer mesenchymal transition gene
expression signature is associated with prolonged time to
recurrence in glioblastoma. PLoS One. 7:e347052012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian L, Shen D, Li X, Shan X, Wang X, Yan
Q and Liu J: Ginsenoside Rg3 inhibits epithelial-mesenchymal
transition (EMT) and invasion of lung cancer by down-regulating
FUT4. Oncotarget. 7:1619–1632. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wijnhoven BP, Dinjens WN and Pignatelli M:
E-cadherin-catenin cell-cell adhesion complex and human cancer. BR
J Surg. 87:992–1005. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: Emt: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaowinn S, Kim J, Lee J, Shin DH, Kang CD,
Kim DK, Lee S, Kang MK, Koh SS, Kim SJ and Chung YH: Cancer
upregulated gene 2 induces epithelial-mesenchymal transition of
human lung cancer cells via TGF-β signaling. Oncotarget.
8:5092–5110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee J, Byun HJ, Lee MS, Jin YJ, Jeoung D,
Kim YM and Lee H: The metastasis suppressor CD82/KAI1 inhibits
fibronectin adhesion-induced epithelial-to-mesenchymal transition
in prostate cancer cells by repressing the associated integrin
signaling. Oncotarget. 8:1641–1654. 2017.PubMed/NCBI
|
|
12
|
Lu L, Wang J, Wu Y, Wan P and Yang G:
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38
and notch signaling. Cancer Med. 5:3544–3554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ci Y, Qiao J and Han M: Molecular
mechanisms and metabolomics of natural polyphenols interfering with
breast cancer metastasis. Molecules. 21:E16342016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du B and Shim JS: Targeting
epithelial-mesenchymal transition (EMT) to overcome drug resistance
in cancer. Molecules. 21:E9652016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim HK, Bae W, Lee HS and Jung J:
Anticancer activity of marine sponge Hyrtios sp. extract in human
colorectal carcinoma RKO cells with different p53 status. BioMed
Res Int. 2014:4135752014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bent S and Ko R: Commonly used herbal
medicines in the United States: A review. Am J Med. 116:478–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nocerino E, Amato M and Izzo AA: The
aphrodisiac and adaptogenic properties of ginseng. Fitoterapia. 71
Suppl 1:S1–S5. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng Y, Shen LH and Zhang JT:
Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and
its mechanism of action. Acta Pharmacol Sin. 26:143–149. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong H, Bai LP, Wong VK, Zhou H, Wang JR,
Liu Y, Jiang ZH and Liu L: The in vitro structure-related
anti-cancer activity of ginsenosides and their derivatives.
Molecules. 16:10619–10630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ,
Kim MJ, Kim HS, Ha J, Kim MS and Kwon DY: Anti-obesity effects of
ginsenoside Rh2 are associated with the activation of AMPK
signaling pathway in 3T3-L1 adipocyte. Biochemical Biophys Res
Commun. 364:1002–1008. 2007. View Article : Google Scholar
|
|
21
|
Jovanovski E, Bateman EA, Bhardwaj J,
Fairgrieve C, Mucalo I, Jenkins AL and Vuksan V: Effect of
Rg3-enriched Korean red ginseng (Panax ginseng) on arterial
stiffness and blood pressure in healthy individuals: A randomized
controlled trial. J Am Soc Hypertens. 8:537–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim J, Han BJ, Kim H, Lee JY, Joo I, Omer
S, Kim YS and Han Y: Th1 immunity induction by ginsenoside Re
involves in protection of mice against disseminated candidiasis due
to Candida albicans. Int Immunopharmacol. 14:481–486. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oh SJ, Lee S, Choi WY and Lim CJ: Skin
anti-photoaging properties of ginsenoside Rh2 epimers in
UV-B-irradiated human keratinocyte cells. J Biosci. 39:673–682.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T
and Liu Y: EGFR signaling-dependent inhibition of glioblastoma
growth by ginsenoside Rh2. Tumour Biol. 35:5593–5598. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang XP, Tang GD, Fang CY, Liang ZH and
Zhang LY: Effects of ginsenoside Rh2 on growth and migration of
pancreatic cancer cells. World J Gastroenterol. 19:1582–1592. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chung KS, Cho SH, Shin JS, Kim DH, Choi
JH, Choi SY, Rhee YK, Hong HD and Lee KT: Ginsenoside Rh2 induces
cell cycle arrest and differentiation in human leukemia cells by
upregulating TGF-β expression. Carcinogenesis. 34:331–340. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Hong B, Wu S and Niu T:
Inhibition of prostatic cancer growth by ginsenoside Rh2. Tumour
Biol. 36:2377–2381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y,
Cao L, Liu Z and Jia C: Ginsenoside rh2 inhibits cancer stem-like
cells in skin squamous cell carcinoma. Cell Physiol Biochem.
36:499–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Li Y, Wang X, Fang X, He K, Guo X,
Zhan Z, Sun C and Jin YH: Co-treatment with ginsenoside Rh2 and
betulinic acid synergistically induces apoptosis in human cancer
cells in association with enhanced capsase-8 activation, bax
translocation and cytochrome c release. Mol Carcinog. 50:760–769.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo H, Luo H, Yuan H, Xia Y, Shu P, Huang
X, Lu Y, Liu X, Keller ET, Sun D, et al: Litchi seed extracts
diminish prostate cancer progression via induction of apoptosis and
attenuation of EMT through Akt/GSK-3β signaling. Sci Rep.
7:416562017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toh DF, Patel DN, Chan EC, Teo A, Neo SY
and Koh HL: Anti-proliferative effects of raw and steamed extracts
of Panax notoginseng and its ginsenoside constituents on human
liver cancer cells. Chin Med. 6:42011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang ZG, Sun HX and Ye YP: Ginsenoside Rd
from Panax notoginseng is cytotoxic towards HeLa cancer cells and
induces apoptosis. Chem Biodivers. 3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Unlu A, Nayir E, Kirca O, Ay H and Ozdogan
M: Ginseng and cancer. J BUON. 21:1383–1387. 2016.PubMed/NCBI
|
|
35
|
Hafez MM, Hamed SS, El-Khadragy MF, Hassan
ZK, Al Rejaie SS, Sayed-Ahmed MM, Al-Harbi NO, Al-Hosaini KA,
Al-Harbi MM, Alhoshani AR, et al: Effect of ginseng extract on the
TGFβ1 signaling pathway in CCl4-induced liver fibrosis in rats. BMC
Complement Altern Med. 17:452017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng X, Chen W, Hou H, Li J, Li H, Sun X,
Zhao L and Li X: Ginsenoside 20(S)-Rg3 induced autophagy to inhibit
migration and invasion of ovarian cancer. Biomed Pharmacother.
85:620–626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lahiani MH, Eassa S, Parnell C, Nima Z,
Ghosh A, Biris AS and Khodakovskaya MV: Carbon nanotubes as
carriers of Panax ginseng metabolites and enhancers of ginsenosides
Rb1 and Rg1 anti-cancer activity. Nanotechnology. 28:0151012017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang J, Yuan D, Xing T, Su H, Zhang S, Wen
J, Bai Q and Dang D: Ginsenoside Rh2 inhibiting HCT116 colon cancer
cell proliferation through blocking PDZ-binding kinase/T-LAK
cell-originated protein kinase. J Ginseng Res. 40:400–408. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu X, Sun Y, Yue L, Li S, Qi X, Zhao H,
Yang Y, Zhang C and Yu H: JNK pathway and relative transcriptional
factor were involved in ginsenoside Rh2-mediated G1 growth arrest
and apoptosis in human lung adenocarcinoma A549 cells. Genet Mol
Res. 15:2016. View Article : Google Scholar
|
|
40
|
Shi Q, Shi X, Zuo G, Xiong W, Li H, Guo P,
Wang F, Chen Y, Li J and Chen DL: Anticancer effect of
20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating
GSK-3β and degrading beta-catenin. Oncol Rep. 36:2059–2070. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qian J, Li J, Jia JG, Jin X, Yu DJ, Guo
CX, Xie B and Qian LY: Ginsenoside-Rh2 inhibits proliferation and
induces apoptosis of human gastric cancer SGC-7901 side population
cells. Asian Pac J Cancer Prev. 17:1817–1821. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wanderi C, Kim E, Chang S, Choi C and Choi
K: Ginsenoside 20(S)-protopanaxadiol suppresses viability of human
glioblastoma cells via down-regulation of cell adhesion proteins
and cell-cycle arrest. Anticancer Res. 36:925–932. 2016.PubMed/NCBI
|
|
43
|
Lim S, Yoon JW, Choi SH, Cho BJ, Kim JT,
Chang HS, Park HS, Park KS, Lee HK, Kim YB and Jang HC: Effect of
ginsam, a vinegar extract from Panax ginseng, on body weight and
glucose homeostasis in an obese insulin-resistant rat model.
Metabolism. 58:8–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee HM, Lee OH, Kim KJ and Lee BY:
Ginsenoside Rg1 promotes glucose uptake through activated AMPK
pathway in insulin-resistant muscle cells. Phytother Res.
26:1017–1022. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ge Y and Chen J: Mammalian target of
rapamycin (mTOR) signaling network in skeletal myogenesis. J Biol
Chem. 287:43928–43935. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Toker A and Yoeli-Lerner M: Akt signaling
and cancer: Surviving but not moving on. Cancer Res. 66:3963–3966.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Frame S and Cohen P: GSK3 takes centre
stage more than 20 years after its discovery. Biochem J. 359:1–16.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Harwood AJ: Regulation of GSK-3: A
cellular multiprocessor. Cell. 105:821–824. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thiery JP: Epithelial-mesenchymal
transitions in cancer onset and progression. Bull Acad Natl Med.
193:1969. 2009.(In French). PubMed/NCBI
|
